KPRX logo

Kiora Pharmaceuticals, Inc. Common Stock


KPRX: Kiora Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company. It focuses on developing and commercializing products for treating diseases and disorders of the eye. It operates in one reportable segment operations and manages.


Show KPRX Financials

Consumer Interest
SEC Filings

Recent trades of KPRX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by KPRX's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Compounds for treating ophthalmic diseases and disorders Aug. 22, 2023
  • Patent Title: Compositions and methods for treatment of ocular diseases Jul. 05, 2022
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of KPRX in WallStreetBets Daily Discussion


Recent insights relating to KPRX

CNBC Recommendations

Recent picks made for KPRX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in KPRX

Corporate Flights

Flights by private jets registered to KPRX